Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability - Trial NCT06382818
Access comprehensive clinical trial information for NCT06382818 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle and is currently Not yet recruiting. The study focuses on Breast Cancer. Target enrollment is 854 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institut du Cancer de Montpellier - Val d'Aurelle
Timeline & Enrollment
N/A
Apr 26, 2024
Apr 26, 2036
Primary Outcome
Rate of patients without any grade 2 or more fibrosis, nor radio-induced sarcoma
Summary
Our objective is based on a personalized approach of adjuvant breast radiotherapy by
 selecting patients according to tumor recurrence and toxicity risk.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06382818
Non-Device Trial